BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatosis
1
Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:32 AM | Browse: 312 | Download: 668
2
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
12/26/2025 10:27:34 AM | Browse: 435 | Download: 858
3
Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease
10/27/2025 10:57:53 AM | Browse: 464 | Download: 825
4
Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion
4/18/2025 8:22:26 AM | Browse: 187 | Download: 612
5
Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease
4/11/2025 2:19:32 AM | Browse: 363 | Download: 1357
6
Prospects of elafibranor in treating alcohol-associated liver diseases
12/18/2024 7:36:02 AM | Browse: 280 | Download: 852
7
Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
10/21/2024 7:03:25 AM | Browse: 260 | Download: 823
8
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
12/6/2023 8:08:49 AM | Browse: 647 | Download: 1758
9
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 672 | Download: 1591
10
Pancreatic fat in type 2 diabetes: Causal or coincidental?
3/1/2023 6:11:27 AM | Browse: 690 | Download: 1447
11
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
7/4/2022 12:30:52 PM | Browse: 874 | Download: 1799
12
Metabolic aspects of hepatitis C virus
6/10/2022 5:40:20 AM | Browse: 867 | Download: 2098
13
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 931 | Download: 1742
14
Glycogen hepatopathy in type-1 diabetes mellitus: A case report
2/22/2022 9:25:38 AM | Browse: 865 | Download: 1707
15
Nonalcoholic fatty liver disease shows significant sex dimorphism
2/11/2022 5:55:19 AM | Browse: 870 | Download: 2146
16
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
1/21/2022 8:16:14 AM | Browse: 1132 | Download: 2165
17
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
10/20/2021 7:18:39 AM | Browse: 893 | Download: 1581
18
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 1209 | Download: 1914
19
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
8/4/2021 7:56:20 AM | Browse: 1031 | Download: 2534
20
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
7/12/2021 12:42:13 AM | Browse: 1165 | Download: 2325
21
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 1084 | Download: 2830
22
Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
6/18/2021 5:06:16 AM | Browse: 1117 | Download: 2322
23
Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients
5/8/2021 7:57:00 AM | Browse: 1101 | Download: 2298
24
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
3/18/2021 10:54:40 AM | Browse: 1209 | Download: 1893
25
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
2/5/2021 10:20:18 AM | Browse: 1196 | Download: 3510
26
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
11/24/2020 12:41:21 PM | Browse: 1198 | Download: 2809
27
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
11/6/2020 7:36:12 AM | Browse: 1324 | Download: 3015
28
Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis
9/4/2020 7:25:49 AM | Browse: 1192 | Download: 3415
29
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
8/7/2019 7:09:17 AM | Browse: 1523 | Download: 2064
30
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 1512 | Download: 1732
31
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 1788 | Download: 2984
32
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1747 | Download: 2613
33
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 1668 | Download: 2350
34
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
1/21/2019 5:38:30 AM | Browse: 1647 | Download: 2063
35
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 1791 | Download: 2526
36
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 1468 | Download: 2535
37
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
9/25/2018 3:44:36 AM | Browse: 1696 | Download: 2461
38
Feasibility of using marginal liver grafts in living donor liver transplantation
6/15/2018 9:13:16 AM | Browse: 1732 | Download: 2183
39
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 1723 | Download: 2257
40
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1785 | Download: 3441
41
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
1/19/2018 9:46:49 AM | Browse: 1570 | Download: 2621
42
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 1750 | Download: 2550
43
Non-alcoholic fatty liver disease: An expanded review
6/6/2017 12:54:56 AM | Browse: 2026 | Download: 2177
44
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
5/20/2017 12:26:24 PM | Browse: 2143 | Download: 2292
45
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
5/16/2017 6:56:36 AM | Browse: 2030 | Download: 3371
46
Non-alcoholic fatty liver disease and cardiovascular risk
5/16/2017 6:56:36 AM | Browse: 1920 | Download: 2150
47
Changes in human hepatic metabolism in steatosis and cirrhosis
4/20/2017 3:58:56 PM | Browse: 2244 | Download: 3487
48
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 2052 | Download: 3019
49
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
12/27/2016 8:31:00 AM | Browse: 2108 | Download: 3758
50
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 1981 | Download: 2558